The Selective JAK1/3-Inhibitor R507 Mitigates Obliterative Airway Disease Both With Systemic Administration and Aerosol Inhalation
2016 ◽
Vol 100
(5)
◽
pp. 1022-1031
◽
Keyword(s):
2001 ◽
Vol 20
(2)
◽
pp. 166
2002 ◽
Vol 74
(4)
◽
pp. 557-562
◽
2011 ◽
Vol 30
(4)
◽
pp. S119
2003 ◽
Vol 22
(9)
◽
pp. 1014-1022
◽
2011 ◽
Vol 37
(7)
◽
pp. 435-444
◽
2006 ◽
Vol 34
(1)
◽
pp. 108-118
◽